- Home
- SNY vs BMO Comparison
SNY vs BMO Comparison
Compare SNY & BMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNY | BMO |
|---|---|---|
| Founded | 1994 | 1817 |
| Country | France | Canada |
| Employees | 74846 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.3B | 93.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SNY | BMO |
|---|---|---|
| Price | $48.12 | $153.39 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $58.00 | ★ $163.00 |
| AVG Volume (30 Days) | ★ 2.5M | 663.7K |
| Earning Date | 04-23-2026 | 05-27-2026 |
| Dividend Yield | ★ 3.33% | 3.12% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.49 | $19.43 |
| Revenue Next Year | $6.10 | $4.27 |
| P/E Ratio | ★ $6.14 | $17.46 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $43.32 | $92.94 |
| 52 Week High | $55.73 | $153.67 |
Technical Indicators
Market Signals| Indicator | SNY | BMO |
|---|---|---|
| Relative Strength Index (RSI) | 60.70 | 73.34 |
| Support Level | $46.68 | $122.60 |
| Resistance Level | $48.49 | N/A |
| Average True Range (ATR) | 0.68 | 2.37 |
| MACD | 0.12 | 1.75 |
| Stochastic Oscillator | 80.43 | 97.61 |
Price Performance
Historical ComparisonAbout SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About BMO Bank Of Montreal
Bank of Montreal is a diversified financial-services provider based in North America with over CAD 1.4 trillion in assets. BMO operates four business segments: Canadian personal and commercial banking, US personal and commercial banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the US.